Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).

MLA

Krzyscik, Mateusz Adam, et al. “Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).” Molecular Pharmaceutics, vol. 17, no. 7, July 2020, pp. 2734–48. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.0c00419.

APA

Krzyscik, M. A., Zakrzewska, M., & Otlewski, J. (2020). Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1). Molecular Pharmaceutics, 17(7), 2734–2748. https://doi.org/10.1021/acs.molpharmaceut.0c00419

Chicago

Krzyscik, Mateusz Adam, Małgorzata Zakrzewska, and Jacek Otlewski. 2020. “Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1).” Molecular Pharmaceutics 17 (7): 2734–48. doi:10.1021/acs.molpharmaceut.0c00419.